Safety of NAD+ Injections with Adderall
NAD+ injections should be avoided when taking Adderall due to lack of safety data and potential risk for drug interactions affecting cardiovascular function.
Understanding the Medications
Adderall
- Combination of amphetamine and dextroamphetamine
- DEA Schedule II controlled substance with high potential for abuse 1
- Stimulates release of norepinephrine affecting both α- and β-adrenergic receptor sites
- α-Adrenergic stimulation causes vasoconstriction and increases total peripheral resistance
- β-Adrenergic stimulation increases heart rate, stroke volume, and skeletal muscle blood flow 1
NAD+ (Nicotinamide Adenine Dinucleotide)
- Essential pyridine nucleotide cofactor involved in:
- Oxidative phosphorylation
- ATP production
- DNA repair
- Calcium-dependent secondary messaging
- Gene expression 2
Safety Concerns
Lack of Drug Interaction Data
- No published studies or guidelines specifically address interactions between NAD+ injections and Adderall
- The practice parameter for stimulant medications does not mention NAD+ as a safe combination therapy 3
- Current clinical guidelines focus on established medication combinations with known safety profiles
Cardiovascular Risks
- Adderall causes significant cardiovascular effects including:
- Tachycardia
- Increased blood pressure
- Vasoconstriction 1
- NAD+ supplementation has been shown to affect:
- Maximum heart rate
- Cardiovascular parameters 2
- The combined cardiovascular effects of both substances are unknown and potentially dangerous
Reported Side Effects
Adderall Side Effects
- Hyperactivity
- Hyperthermia
- Tachycardia
- Tachypnea
- Mydriasis
- Tremors
- Seizures 1
NAD+ Side Effects
- Muscle pain
- Nervous disorders
- Fatigue
- Sleep disturbance
- Headaches 2
Clinical Decision Making
Risk Assessment
- High-risk combination: Both substances affect cardiovascular function through different mechanisms
- Unknown interaction profile: No established safety data for this specific combination
- Potential for additive adverse effects: Both can cause nervous system effects and fatigue
Alternative Approaches
If considering NAD+ supplementation while on Adderall:
- Oral NAD+ precursors may be safer than injections, as they have been more extensively studied 4
- Timing separation between medications may reduce potential interactions (though this is theoretical without evidence)
- Monitoring of cardiovascular parameters would be essential if attempting this combination
Recommendations for Specific Populations
Patients with Pre-existing Conditions
- Cardiovascular disease: Absolutely contraindicated due to additive cardiovascular risks
- Seizure disorders: High risk due to potential lowering of seizure threshold with stimulants 3
- Hypertension: Increased risk of hypertensive crisis
Medication Combinations to Avoid
- MAO inhibitors: Absolutely contraindicated with Adderall - can cause severe hypertension and cerebrovascular accidents 3
- Adding NAD+ injections to this already risky landscape introduces unnecessary uncertainty
Conclusion
Given the lack of safety data and the potential for serious cardiovascular effects, NAD+ injections should be avoided in patients taking Adderall until proper clinical studies establish their safety profile together. The risk of unknown drug interactions outweighs the potential benefits of this combination.